COMPANIES COVERED
Edwards LifesciencesDownload FREE Report Sample
Download Free sampleAn?artificial heart valve?is a device implanted into the?heart?of a patient to replace a dysfunctional native?heart valve?(valvular?heart?disease).?
Artificial Heart Valve Market contains market size and forecasts of Artificial Heart Valve in global, including the following market information:
Global Artificial Heart Valve Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Artificial Heart Valve Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Artificial Heart Valve companies in 2021 (%)
The global Artificial Heart Valve market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Transcatheter Heart Valves Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Artificial Heart Valve include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific Corporation, LivaNova, Symetis, Jenavalve Technology, Cryolife and TTK Healthcare Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Artificial Heart Valve manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Heart Valve Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Artificial Heart Valve Market Segment Percentages, by Type, 2021 (%)
Transcatheter Heart Valves
Tissue Heart Valves
Mechanical Heart Valves
Global Artificial Heart Valve Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Artificial Heart Valve Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Artificial Heart Valve Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Artificial Heart Valve Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Heart Valve revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Artificial Heart Valve revenues share in global market, 2021 (%)
Key companies Artificial Heart Valve sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Artificial Heart Valve sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific Corporation
LivaNova
Symetis
Jenavalve Technology
Cryolife
TTK Healthcare Limited
Colibri Heart Valve
Lepu Medical Technology
Braile Biom?dica
Micro Interventional
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy